Antibiotic Stewardship in the Neonatal Intensive Care Unit

Area of Science:

• Neonatal Medicine
• Infectious Diseases
• Pharmacology

Background:

• Neonates, especially preterm infants in NICUs, experience high antibiotic exposure rates.
• Exposure to antibiotics without infection carries adverse consequences, contributing to antibiotic resistance.
• Antibiotic resistance is a growing global health threat, with unique challenges in the NICU setting.

Purpose of the Study:

• To review general antibiotic stewardship principles applicable to NICUs.
• To discuss unique implementation strategies and considerations for NICU patients.
• To highlight specific antibiotic resistance threats within the NICU.

Main Methods:

• Review of general antibiotic stewardship principles.
• Discussion of NICU-specific patient and setting characteristics.
• Summary of current antibiotic use metrics and infection prevention practices.
• Review of empiric antibiotic use recommendations and infection biomarkers.

Main Results:

• Antibiotic stewardship requires tailored approaches for NICUs due to unique patient populations and risks.
• Effective stewardship involves monitoring antibiotic use metrics and implementing evidence-based infection prevention.
• Understanding NICU-specific resistance threats is crucial for optimizing antibiotic use.

Conclusions:

• Implementing antibiotic stewardship in NICUs is essential for optimizing antibiotic use and combating resistance.
• Specialized strategies are needed to address the unique vulnerabilities of neonates to antibiotic exposure.
• Further focus on infection prevention and judicious antibiotic selection is critical in the NICU.